Trevi Therapeutics, Inc.
TRVI • NASDAQ
Trevi Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer L. Good, with a market cap of $1.5B.
CEOJennifer L. Good
Next Earnings
Upcoming earnings announcement for Trevi Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.07
Earnings History
Past 12 earnings reports for Trevi Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.06Est: -$0.10 | +40.0% | - | — | — |
| Nov 13, 2025 | Q3 2025 | -$0.08Est: -$0.10 | +20.0% | - | — |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.09Est: -$0.10 | +10.0% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.09Est: -$0.12 | +25.0% | - | — | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.11Est: -$0.12 | +8.3% | - | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.13Est: -$0.12 | -8.3% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.12Est: -$0.11 | -9.1% | - | — | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.11Est: -$0.10 | -10.0% | - | — | 10-Q |
| Mar 20, 2024 | Q4 2023 | -$0.08Est: -$0.09 | +11.1% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.08Est: -$0.09 | +11.1% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.07Est: -$0.08 | +12.5% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.06Est: -$0.07 | +14.3% | - | — | 10-Q |